GenSigth attended ISOPT 2015 in Berlin, Germany.

Jose Alain Sahel MD, CHNO Institut de la Vision, GenSight-Biologics Share Holder and Consultant and Scott Uretsky MD, Neuro-Ophthalmology, Clinical Develoment Director, GenSight-Biologics, gave an oral presentation on : A Recombinant AAV2/2 Carrying the Wild-Type ND4 Gene for the Treatment of LHON: Preliminary Results of a First-In-Man Study and Upcoming Pivotal Efficacy Trials.